Načítá se...
Novel mechanism of drug resistance to proteasome inhibitors in multiple myeloma
Multiple myeloma (MM) is a cancer caused by uncontrolled proliferation of antibody-secreting plasma cells in bone marrow, which represents the second most common hematological malignancy. MM is a highly heterogeneous disease and can be classified into a spectrum of subgroups based on their molecular...
Uloženo v:
| Vydáno v: | World J Clin Oncol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Baishideng Publishing Group Inc
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6766463/ https://ncbi.nlm.nih.gov/pubmed/31572666 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5306/wjco.v10.i9.303 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|